Prescription pattern of Chinese herbal products for diabetes mellitus in Taiwan: A population-based study

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Huang, Chung Yu ^a,b   Tsai, Yueh Ting ^a   Lai, Jung Nien ^a,c   Hsu, Feng Lin ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HACHIMIJIOGAN; HERBACEOUS AGENT; JI SHENG SHEN QI WAN; LIU WEI DI HUANG WAN; PLACEBO; QI JU DI HUANG WAN; UNCLASSIFIED DRUG; ZHI BO DI HUANG WAN;

ADULT; AGED; ARTICLE; CHINESE MEDICINE; DIABETIC PATIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PRIORITY JOURNAL; TAIWAN;

EID: 84880207019     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/201329     Document Type: Article

References (54)

1. Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 5 1047 1053 2-s2.0-2342466734 10.2337/diacare.27.5.1047
2. American Diabetes Association, Economic consequences of diabetes mellitus in the US in 2002. Diabetes Care 2003 26 3 917 932
3. Chang C. H., Shau W. Y., Jiang Y. D., Li H. Y., Chang T. J., H.-H. Sheu W. W., Kwok C. F., Ho L. T., Chuang L. M., Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabetic Medicine 2010 27 6 636 643 2-s2.0-77952720287 10.1111/j.1464-5491.2010.03007.x
4. Harris M. I., Klein R., Welborn T. A., Knuiman M. W., Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992 15 7 815 819 2-s2.0-0026735891
5. Yang W. C., Hwang S. J., Chiang S. S., Chen H. F., Tsai S. T., The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan. Diabetes Research and Clinical Practice 2001 54 supplement 1 S47 S54 2-s2.0-0034813341
6. Roglic G., Unwin N., Mortality attributable to diabetes: estimates for the year 2010. Diabetes Research and Clinical Practice 2010 87 1 15 19 2-s2.0-73749086904 10.1016/j.diabres.2009.10.006
7. Lu T. H., Kwok C. F., Ho L. T., Whether to report diabetes as the underlying cause-of-death? A survey of internists of different sub-specialties. BMC Endocrine Disorders 2010 10, article 13 2-s2.0-77954813270 10.1186/1472-6823-10-13
8. Rao A. D., Kuhadiya N., Reynolds K., Fonseca V. A., Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all- cause mortality? Diabetes Care 2008 31 8 1672 1678 2-s2.0-49649098865 10.2337/dc08-0167
9. Lipscombe L. L., Thiazolidinediones: do harms outweigh benefits? Canadian Medical Association Journal 2009 180 1 16 17
10. Diabetes magazine American Diabetes Association, Diabetes 101: Metformin. April 2013, http://forecast.diabetes.org/diabetes-101/metformin
11. Friedewald W. T., Buse J. B., Bigger J. T., Byington R. P., Cushman W. C., Gerstein H. C., Ginsberg H. N., Goff D. C., Grimm R. H., Ismail-Beigi F., Probstfield J. L., Simons-Morton D. G., Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine 2008 358 24 2545 2559 2-s2.0-45149131667 10.1056/NEJMoa0802743
12. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., Hamet P., Harrap S., Heller S., Liu L., Mancia G., Mogensen C. E., Pan C., Poulter N., Rodgers A., Williams B., Bompoint S., de Galan B. E., Joshi R., Travert F., Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine 2008 358 24 2560 2572
13. Huang E. S., Brown S. E. S., Ewigman B. G., Foley E. C., Meltzer D. O., Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007 30 10 2478 2483 2-s2.0-35148821008 10.2337/dc07-0499
14. Manya K., Champion B., Dunning T., The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complementary and Alternative Medicine 2012 12, article 2
15. Yeh G. Y., Eisenberg D. M., Davis R. B., Phillips R. S., Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey. American Journal of Public Health 2002 92 10 1648 1652 2-s2.0-0036788380
16. Hikino H., Yoshizawa M., Suzuki Y., Oshima Y., Konno C., Isolation and hypoglycemic activity of trichosans A, B, C, D, and E: glycans of Trichosanthes kirilowii roots. Planta Medica 1989 55 4 349 350 2-s2.0-0024322437
17. Xiong F. L., Sun X. H., Gan L., Yang X. L., Xu H. B., Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. European Journal of Pharmacology 2006 529 1-3 1 7 2-s2.0-29344444326 10.1016/j.ejphar.2005.10.024
18. Kako M., Miura T., Usami M., Kato A., Kadowaki S., Hypoglycemic effect of the rhizomes of ophiopogonis tuber in normal and diabetic mice. Biological and Pharmaceutical Bulletin 1995 18 5 785 787 2-s2.0-0029054074
19. Akilen R., Tsiami A., Devendra D., Robinson N., Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabetic Medicine 2010 27 10 1159 1167 2-s2.0-77956863768 10.1111/j.1464-5491.2010.03079.x
20. Ping H., Zhang G., Ren G., Antidiabetic effects of cinnamon oil in diabetic KK-A(y) mice. Food and Chemical Toxicology 2010 48 8 2344 2349
21. Kim H. J., Kong M. K., Kim Y. C., Beneficial effects of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy in streptozotocin- induced diabetic rats. Journal of Biochemistry and Molecular Biology 2008 41 10 710 715 2-s2.0-55249124337
22. Liou S. S., Liu I. M., Lai M. C., The plasma glucose lowering action of Hei-Shug-Pian, the fire-processed product of the root of Aconitum (Aconitum carmichaeli), in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 2006 106 2 256 262 2-s2.0-33646889750 10.1016/j.jep.2006.01. 001
23. Zhang R., Zhou J., Jia Z., Zhang Y., Gu G., Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. Journal of Ethnopharmacology 2004 90 1 39 43 2-s2.0-0347123329 10.1016/j.jep.2003.09.018
24. Chen C. C., Hsu C. Y., Chen C. Y., Liu H. K., Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death. Journal of Ethnopharmacology 2008 117 3 483 490 2-s2.0-42949179698 10.1016/j.jep.2008.02.032
25. Chung S. H., Choi C. G., Park S. H., Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Archives of Pharmacal Research 2001 24 3 214 218 2-s2.0-0035380884
26. Ko B. S., Jang J. S., Hong S. M., Sung S. R., Lee J. E., Lee M. Y., Jeon W. K., Park S., Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis fisch, modify insulin sensitizing and insulinotropic actions. Bioscience, Biotechnology and Biochemistry 2007 71 6 1452 1461 2-s2.0-34347329278 10.1271/bbb.60533
27. Kim J. H., Chung H. S., Kang M., Kim Y., Kim B. S., Kim Y. S., Bae H., Anti-diabetic effect of standardized herbal formula PM021 consisting of Mori Folium and Aurantii Fructus on type II diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Diabetes Research and Clinical Practice 2011 93 2 198 204
28. Potterat O., Goji (Lycium barbarum and L. chinense): phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Medica 2010 76 1 7 19 2-s2.0-74349093922 10.1055/s-0029- 1186218
29. Birdee G. S., Yeh G., Complementary and alternative medicine therapies for diabetes: a Clinical Review. Clinical Diabetes 2010 28 4 147 155 2-s2.0-78149462996 10.2337/diaclin.28.4.147
30. Hsieh S. C., Lai J. N., Lee C. F., Hu F. C., Tseng W. L., Wang J. D., The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database. Pharmacoepidemiology and Drug Safety 2008 17 6 609 619 2-s2.0-46349110645 10.1002/pds.1611
31. Chen F. P., Chen T. J., Kung Y. Y., Chen Y. C., Chou L. F., Chen F. J., Hwang S. J., Use frequency of traditional Chinese medicine in Taiwan. BMC Health Services Research 2007 7, article 26 2-s2.0-33847685804 10.1186/1472-6963-7-26
32. Lai J. N., Wu C. T., Wang J. D., Prescription pattern of Chinese herbal products for breast cancer in Taiwan: a population-based study. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 891893 10.1155/2012/891893
33. Fang R. C., Tsai Y. T., Lai J. N., Yeh C. H., Wu C. T., The traditional Chinese medicine prescription pattern of endometriosis patients in Taiwan: a population-based study. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 591391 10.1155/2012/591391
34. Yang Y. H., Chen P. C., Wang J. D., Lee C. H., Lai J. N., Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan. Climacteric 2009 12 6 541 547 2-s2.0-70449635596 10.3109/13697130903060081
35. Lee Y. C., Huang Y. T., Tsai Y. W., Huang S. M., Kuo K. N., McKee M., Nolte E., The impact of universal National Health Insurance on population health: the experience of Taiwan. BMC Health Services Research 2010 10, article 225 2-s2.0-77955105224 10.1186/1472-6963-10-225
36. Institutes N. H. R., National Health Insurance Research database. March 2011, http://nhird.nhri.org.tw/date-01.html
37. Prevention C. F. D. A., International Classification of Diseases, Ninth Revision (ICD-9). March 2011, http://www.cdc.gov/nchs/icd/icd9.htm
38. Lin C. C., Lai M. S., Syu C. Y., Chang S. C., Tseng F. Y., Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. Journal of the Formosan Medical Association 2005 104 3 157 163 2-s2.0-19144370601
39. Chien K., Cai T., Hsu H., Su T., Chang W., Chen M., Lee Y., Hu F. B., A prediction model for type 2 diabetes risk among Chinese people. Diabetologia 2009 52 3 443 450 2-s2.0-59449099375 10.1007/s00125-008-1232-4
40. Tseng C. H., Tseng C. P., Chong C. K., Huang T. P., Song Y. M., Chou C. W., Lai S. M., Tai T. Y., Cheng J. C., Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006 49 8 1755 1760 2-s2.0-33745799034 10.1007/s00125-006-0314-4
41. Cheng S. F., Hsu H. H., Lee H. S., Lin C. S., Chou Y. C., Tien J. H., Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan. Journal of Clinical Pharmacy and Therapeutics 2004 29 6 547 558 2-s2.0-10844232895 10.1111/j.1365-2710.2004. 00599.x
42. UK Prospective Diabetes Study 6, Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Research 1990 13 1 1 11
43. Diabetes UK, Diabetes in the UK 2010: key statistics on diabetes. March 2010, http://zh.scribd.com/doc/45658612/Diabetes-in-the-UK-2010
44. Thomas K., Coleman P., Use of complementary or alternative medicine in a general population in Great Britain. Results from the National Omnibus survey. Journal of Public Health 2004 26 2 152 157 2-s2.0-3543124720
45. Colagiuri S., Colagiuri R., Na'ati S., Muimuiheata S., Hussain Z., Palu T., The prevalence of diabetes in the Kingdom of Tonga. Diabetes Care 2002 25 8 1378 1383 2-s2.0-0036673451 10.2337/diacare.25.8.1378
46. Dunstan D. W., Zimmet P. Z., Welborn T. A., De Courten M. P., Cameron A. J., Sicree R. A., Dwyer T., Colagiuri S., Jolley D., Knuiman M., Atkins R., Shaw J. E., The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care 2002 25 5 829 834 2-s2.0-0036582654 10.2337/diacare.25.5.829
47. Malik M., Bakir A., Abi Saab B., Roglic G., King H., Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. Diabetes Research and Clinical Practice 2005 69 2 188 195 2-s2.0-21744461617 10.1016/j.diabres.2004.12.005
48. Danaei G., Friedman A. B., Oza S., Murray C. J. L., Ezzati M., Diabetes prevalence and diagnosis in US states: analysis of health surveys. Population Health Metrics 2009 7, article 1478 16 2-s2.0-70449511788 10.1186/1478-7954-7-16
49. Wong K. C., Wang Z., Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Research and Clinical Practice 2006 73 2 126 134 2-s2.0-33745267713 10.1016/j.diabres.2006. 01.007
50. Poon T. Y., Ong K. L., Cheung B. M., Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications. Journal of Diabetes 2011 3 3 184 200
51. Covington M. B., Traditional Chinese medicine in the treatment of diabetes. Diabetes Spectrum 2001 143 154 159
52. Committee on Chinese Medicine, Pharmacy, Department of Health, Executive Yuan, Taiwan, Six-flavour Rehmannia Pill, Rehmannia Bolus with Six Herbs, Liu Wei Ti Huang Wan, Liu Wei Di Huang Wan. April 2013, http://www.ccmp.gov.tw/en/ information/formula-detail.asp?detailno=19&selno=0&relno=52&PageNo=1
53. Li S., Zhang B., Jiang D., Wei Y., Zhang N., Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010 11 supplement 11, article S6 2-s2.0-78650832745 10.1186/1471-2105-11-S11-S6
54. Shen J. J., Lin C. J., Huang J. L., Hsieh K. H., Kuo M. L., The effect of Liu-Wei-Di-Huang Wan on cytokine gene expression from human peripheral blood lymphocytes. American Journal of Chinese Medicine 2003 31 2 247 257 2-s2.0-0042319331 10.1142/S0192415X03000886